Pharma Stocks With Nice Dividends: The RX Investors Need

Many healthcare stocks have been under the weather this year amid concerns about the advent of weight-loss drugs, weaker Covid-related sales, and the market’s narrow focus on a handful of tech names. “The demographics alone are a huge tailwind for this sector,” says Stephanie Link, chief investment strategist at Hightower Advisors. No doubt, 2023 has been a forgettable year for many healthcare stocks.